US Psychedelic Helpline: Insights from 25,419 Interactions

Related Articles

Psiconáutica Editorial Team · November 17, 2026

In brief

  • A Science Advances paper, published October 30, 2026, describes 25,419 interactions with a US psychedelic support line between April 2021 and February 2026.
  • Most callers sought help during an experience or for post-experience integration; referrals to emergency services (911 or 988) were under 1% for each major substance.
  • The data portrays those who contact a specific service, not all people who use drugs, and the authors are affiliated with the service itself.
Read more  Ketamine and the habenula: aversive responses in 70 healthy adults

The Fireside Project’s psychedelic support line, a US organization with trained volunteers, assists people via phone or text who are in the midst of an experience or wish to process it afterward. The team has now published what it describes as the largest dataset on these types of contacts and has made it available to other researchers.

What was analyzed

Volunteers coded each interaction using a standard form: modality, type of call, substances, context, and—when disclosed—demographic or diagnostic data. 67.5% were calls and 32.5% were text messages. Additionally, 2,777 people (10.9% of interactions) responded to a satisfaction survey after the contact.

What was observed

Reasons and substances

40.2% of interactions were support during an experience, and 32.1% were integration support. 11.6% were classified as “out of scope” (e.g., medical emergencies redirected to 911 or 988), and 10.6% were informational inquiries. Among cases with a recorded substance (15,596), psilocybin predominated (59.9%), followed by LSD (14.4%), cannabis (12.8%), ketamine (7.7%), and MDMA (4.4%).

Distress and emergencies

Reported distress was higher with cannabis in the aggregate data (47.2%), but the majority of those calls occurred during the experience (70.2%), when distress is naturally higher. When separated by call type, differences between substances were not significant. Emergency referrals ranged from 0.08% (ketamine) to 0.65% (cannabis).

Read more  Australia: supervision of MDMA and psilocybin under authorized prescribing

Who calls

Among 7,826 interactions with recorded history, 60.5% reported at least one psychiatric diagnosis: PTSD (18.5%), major depression (16.7%), generalized anxiety (8.8%), and, in 185 cases (2.4%), schizophrenia—a group often excluded from clinical trials. In the known context, 66.3% of callers were alone. There were also 43 interactions (0.2%) reporting abuse by guides or facilitators, which the organization did not verify.

Limitations

The data describes those who sought help, not the general population of users: the authors warn that distress percentages do not equate to population risk and that cannabis, being much more widely used, may generate more calls simply due to volume. Only 30.8% of interactions had a recorded history and only 10.9% had a survey, introducing selection bias; substances are self-reported. The study does not measure whether the line prevented harm and comes from a single service. It was funded by the Fireside Project with its operating funds, and its founder and nearly all signatories are affiliated with the organization, as disclosed.

Implications

The study shows a real demand for support outside of clinical settings, especially with psilocybin, and includes people with diagnoses typically excluded from clinical trials. It does not prove these services are effective or safe in a general sense. Such data helps in designing training and protocols; our harm reduction and responsible use guide provides safety guidelines.

Read more  MDMA and PTSD: seven-trial meta-analysis and its limitations

Sources

  • Schoeller F, Santolini M, Xiadani D, Eskinazi M, Murali A, Esselman D, Houtz W, Bellanca W, White J. “The Fireside Database: Large-scale evidence from 25,419 psychedelic support interactions.” Science Advances 12 (44), October 30, 2026. doi:10.1126/sciadv.aeg4737 (text on PMC).

Image

Illustrative image: a mobile phone on a table. Photo: Santeri Viinamäki, via Wikimedia Commons, licensed under CC BY-SA 4.0.

Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use.

More on this topic

Comments

Advertisementspot_img

Popular stories